The Centers for Disease Control and Prevention (CDC) has provided information
on a multistate outbreak of coagulopathy from exposure to synthetic
cannabinoids products containing a vitamin K-epoxide cycle antagonist,
brodifacoum. To learn more about this outbreak, and what you can do to help
your patients who may be affected by it, please refer to the
CDC?s
alert.